Skip to main content
. 2013 Jun;13(5):681–688. doi: 10.2174/1871520611313050002

Fig. (5).

Fig. (5)

Comparison of the granulocyte/lymphocyte ratio between patients who received (Lentinan+) and those who did not (Lentinan-) using the x2 test [73]. A: Before therapy. B: At either 1 year after initiation of the S-1 based chemotherapy or 1 mo prior to death (cases in which the survival time was < 1 year after starting chemotherapy). P values of less than 0.05 were considered statistically significant. G/L ratio: Granulocyte/lymphocyte ratio.